( xually transmitted infections is a prio...)UK Govt Says On Course For National Chlamydia Screening,Health
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
MEDICINE
>>
NEWS
UK Govt Says On Course For National Chlamydia Screening
xually transmitted infections is a priority for government especially...Since April 2003 78698 people have been screened and over 800...
http://www.bio-medicine.org/inc/biomed/medicine-news.asp
http://feeds.bio-medicine.org/latest-medical-news
xually transmitted infections is a priority for government, especially chlamydia which affects one in 10 sexually active women, the governmenht said.
Since April 2003, 78,698 people have been screened and over 8,000 people have tested positive.
'"/>
Page:
1
2
Related medicine news :
1
.
Launch Of India’s First Virology Course At Pun
2
.
Provisional Fees For Medical Courses Fixed By Punjab Government
3
.
Supreme Court Quashed Reservation Quotas For PG Medical Courses
4
.
RIMS to start A Course On Sports Medicine From Next Year
5
.
Medicos On Collision Course With SC
6
.
Amity Institutions To Launch Short-term Professional Courses In Oman
7
.
Pneumonia Effectively Treated with Short-Term Antibiotic Course
8
.
Child Diarrhoea Due To Rotavirus:Quick Relief By Short Course Drug
9
.
Degree Course In Ayurveda
10
.
Demographic Change Demand a New Life-Course for Aging Society
11
.
Medical Course in Kerala is Beyond the Reach of NRIs
Post Your Comments:
*
Name:
*
Comment:
*
Email:
TAG:
Govt
Says
Course
For
National
Chlamydia
Screening
TAG:
Govt
Says
Course
For
National
Chlamydia
Screening
Breaking Medicine News(10 mins):
Health News:Summa Health System Selects Software Solution Suite from Agilysys 2
Health News:Summa Health System Selects Software Solution Suite from Agilysys 3
Health News:Allscripts Launches New Innovations in Live Event 2
Health News:Allscripts Launches New Innovations in Live Event 3
Health News:Allscripts Launches New Innovations in Live Event 4
Health News:Allscripts Launches New Innovations in Live Event 5
Health News:Allscripts Launches New Innovations in Live Event 6
Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 2
Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 3
Health News:Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium 2
Health News:Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium 3
Health News:Anesiva Receives NASDAQ Listing Compliance Notice 2
Health News:Anesiva Receives NASDAQ Listing Compliance Notice 3
[
0
] Summa Health System Selects Software Solution Suite from Agilysys
[
0
] Allscripts Launches New Innovations in Live Event
[
0
] Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year
[
0
] Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium
[
0
] Anesiva Receives NASDAQ Listing Compliance Notice
Other Medicine News:
Health News:Metal In Medicines Can Fight Diseases Effectively 2
Immunosuppressive drug shows promise in treatment of eye disorder
Bird Flu Risk In Europe, Middle East And Africa
Encephalitis Has Claimed 400 Lives In Uttar Pradesh
'Art of Living' concept expanding around the globe
Metal In Medicines Can Fight Diseases Effectively
Olive oil can do more good than just adding taste to your dish
Breaking Medicine Technology:
Waismann Method Offers Safe and Alternative Treatment for Dependency to Ambien 2
Waismann Method Offers Safe and Alternative Treatment for Dependency to Ambien 3
Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 2
Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 3
Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 4
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6
ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7
Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 1
Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 2
OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 1
OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 2
OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 3
OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 4
OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 5
Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 1
Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 2
Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 3
[
0
] Waismann Method Offers Safe and Alternative Treatment for Dependency to Ambien
[
0
] Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy
[
0
] ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease
Other Medicine Technology:
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 2
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 3
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 4
Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 2
Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine 3
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
Medicine Products:
Precision Bar Code Tags
CompuBand® Thermal Printing Lanyard Snap Wristbands
Endur ID EnduriCuff Plus
IDENTI-MATCH II
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health